Article Data

  • Views 404
  • Dowloads 145

Case Reports

Open Access

Effective multidisciplinary treatment for ovarian granulosa cell tumor with multiple metastases - a case report

  • W. Yamagami1,*,
  • S. Ooki1
  • H. Semba1
  • T. Ninomiya1
  • S. Hayashi1
  • H. Yamashita1
  • H. Arai1

1National Hospital Organization Tokyo Medical Center, Division of Obstetrics and Gynecology, Tokyo, Japan

DOI: 10.12892/ejgo201204370 Vol.33,Issue 4,July 2012 pp.370-375

Published: 10 July 2012

*Corresponding Author(s): W. Yamagami E-mail: gami@z8.keio.jp

Abstract

Ovarian granulosa cell tumor (GCT) is among the ovarian sex-cord stromal tumors that are classified as borderline malignancies. We report a case of GCT with multiple metastases for which multidisciplinary treatment including surgery, chemotherapy and radiotherapy was effective. A 41-year-old woman underwent left salpingo-oophorectomy because of an ovarian tumor in 2004. Final pathology confirmed a granulosa cell tumor adult type, FIGO Stage IC. In 2008, tumorectomy of the lower abdominal wall metastases was also performed. After three cycles of BEP chemotherapy for metastases of the right lung, liver, paraaortic lymph node and rectus, surgical resection was performed in 2009. In 2010, local radiation was performed for the first lumbar vertebral metastasis. Ovarian GCTs exhibit slow growth but if the surgical stage is IC or higher, there is the possibility of recurrence. It is important to treat recurrent tumors with the combination of surgery, chemotherapy, and radiation therapy.

Keywords

Ovarian granulosa cell tumor; Recurrence; BEP

Cite and Share

W. Yamagami,S. Ooki,H. Semba,T. Ninomiya,S. Hayashi,H. Yamashita,H. Arai. Effective multidisciplinary treatment for ovarian granulosa cell tumor with multiple metastases - a case report. European Journal of Gynaecological Oncology. 2012. 33(4);370-375.

References

[1] Malmström H., Högberg T., Risberg B., Simonsen E.: “Granulosa Cell Tumors of the Ovary: Prognostic Factors and Outcome”. Gynecol Oncol., 1994, 52, 50.

[2] Ayhan A., Salman M.C., Velipasaoglu M., Sakinci M., Yuce K.: “Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases”. J. Gynecol. Oncol., 2009, 20, 158

[3] Berek J.S., Natarajan S.: “Ovarian and fallopian tube cancer”. In: Berek J.S. (ed.), Berek & Novak’s Gynecology, 14th edition, Philadelphia, Lippincott Williams & Wilkins, 2006.

[4] Dubuc-Lissoir J., Berthiaume M.J., Boubez G., Van Nguyen T., Allaire G.: “Bone metastasis from a granulosa cell tumor of the ovary”. Gynecol. Oncol., 2001, 83, 400.

[5] Rafii A., Ferron G., Lacroix-Triki M., Dalenc F., Gladieff L., Querleu D.: “Abdominal wall metastasis of ovarian carcinoma after low transverse abdominal incision: report of two cases and review of literature”. Int. J. Gynecol. Cancer, 2006, 16 (suppl. 1), 334.

[6] Schumer S.T., Cannistra S.A.: “Granulosa cell tumor of the ovary”. J. Clin. Oncol., 2003, 21, 1180.

[7] Uygun K., Aydiner A., Saip P., Kocak Z., Basaran M., Dincer M., Topuz E.: “Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary”. Gynecol. Oncol., 2003, 88, 400.

[8] Rha S.E., Oh S.N., Jung S.E., Lee Y.J., Lee A.W., Byun J.Y.: “Recurrent ovarian granulosa cell tumors: clinical and imaging features”. Abdom Imaging, 2008, 33, 119.

[9] Abu-Rustum N.R., Restivo A., Ivy J., Soslow R., Sabbatini P., Sonoda Y. et al.: “Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary”. Gynecol. Oncol., 2006, 103, 31.

[10] Raj G., Proietto A., Jaaback K.: “Positron emission tomography and granulosa cell tumor recurrence: a report of 2 cases”. Int. J. Gynecol Cancer, 2009, 19, 1542.

[11] Chang H.L., Pahlavan N., Halpern E.F., MacLaughlin D.T.: “Serum Mullerian Inhibiting Substance/anti-Mullerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology”. Gynecol. Oncol,. 2009, 114, 57

[12] Homesley H.D., Bundy B.N., Hurteau J.A., Roth L.M.: “Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study”. Gynecol. Oncol., 1999, 72, 131.

[13] Pecorelli S., Wagenaar H.C., Vergote I.B., Curran D., Beex L.V., Wiltshaw E. et al.: “Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study”. Eur. J. Cancer, 1999, 35, 1331.

[14] Wolf J.K., Mullen J., Eifel P.J., Burke T.W., Levenback C., Gershenson D.M.: “Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary”. Gynecol Oncol., 1999, 73, 35.

[15] E C, Samant R., Fung M.F., Le T., Hopkins L., Senterman M.: “Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: a report of 3 cases with radiological evidence of response”. Gynecol. Oncol., 2006, 102, 406

[16] Kim H.J., Lee S.C., Bae S.B., Kwon K.W., Kim C.K., Lee N.S. et al.: “GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors”. J. Korean Med Sci., 2009, 24, 535.

[17] Korach J., Perri T., Beiner M., Davidzon T., Fridman E., Ben-Baruch G.: “Promising effect of aromatase inhibitors on recurrent granulosa cell tumors”. Int. J. Gynecol. Cancer, 2009, 19, 830.

[18] Stewart C.J., Brennan B.A., Crook M.L., Doherty D.A., Hammond I.G., Leuverink E. et al.:” Comparison of proliferation indices in primary adult-type granulosa cell tumors of the ovary and their corresponding metastases: an analysis of 14 cases”. Int. J. Gynecol. Pathol., 2009, 28, 423.

[19] Leuverink E.M., Brennan B.A., Crook M.L., Doherty D.A., Hammond I.G., Ruba S. et al.: “Prognostic value of mitotic counts and Ki-67 immunoreactivity in adult-type granulosa cell tumour of the ovary”. J. Clin. Pathol., 2008, 61, 914.

[20] Nosov V., Silva I., Tavassoli F., Adamyan L., Farias-Eisner R., Schwartz P.E. et al.: “Predictors of recurrence of ovarian granulosa cell tumors”. Int. J. Gynecol. Cancer, 2009, 19, 628.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top